Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on October 6, 2022. The report announces consolidated financial results for the first fiscal quarter ended August 28, 2022.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that the Q1 2022 results have been issued via a press release.
Guidance, Outlook, and Risks
The text contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation (Ticker: LNDC), not Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (the press release) for actual financial figures, as they are absent from the 8-K body text.
- Confirm the fiscal quarter end date of August 28, 2022 for accurate period comparison.
- Note that the financial data in this filing is not incorporated by reference into other filings unless expressly stated.